Get started
Author

Abbass Darwich

Observed names: A Darwich, DARWICH, ABBASS, Darwich Abbass, Darwich, Abbass
Institution: Servier (France)
ORCID: 0000-0001-5540-9303
Observed ORCID: 0000-0001-5540-9303
OpenAlex ID: A5036710605
Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
2021 · Abbass Darwich, Alessandra Silvestri, et al. · Journal for ImmunoTherapy of Cancer · 52
PDF
T-cell-based breast cancer immunotherapy
2020 · Karolina Pilipow, Abbass Darwich, et al. · Seminars in Cancer Biology · 44
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
2022 · Abbass Darwich, Chiara Pozzi, et al. · EMBO Molecular Medicine · 34
A modular and controllable T cell therapy platform for acute myeloid leukemia
2021 · Mohamed-Reda Benmebarek, Bruno L. Cadilha, et al. · Leukemia · 34
PDF
A ‘Multiomic’ Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019
2022 · Chiara Pozzi, Riccardo Levi, et al. · Gastro Hep Advances · 24
Humoral response to anti-SARS-CoV-2 vaccine in breastfeeding mothers and mother-to-infant antibody transfer through breast milk
2022 · Carlo Pietrasanta, Abbass Darwich, et al. · npj Vaccines · 10
PDF
Abstract CT078: Results of a phase 1 first-in-human study of PRS-344/S095012, a PD-L1x4-1BB antibody-Anticalin fusion protein (Mabcalin), in patients with previously treated advanced solid tumors
2025 · Emiliano Calvo, Elena Garralda, et al. · Cancer Research · 1
P07.01 A modular and controllable T cell therapy platform for AML
2021 · M Benmebarek, B Loureiro Cadilha, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Abstract CT077: Pharmacodynamic characterization of PRS-344/S095012, a PD-L1x4-1BB antibody-Anticalin fusion protein (Mabcalin), in a dose escalation study in patients with advanced solid tumors
2025 · Emiliano Calvo, Elena Garralda, et al. · Cancer Research
Dataset related to article "BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?"
2022 · Darwich, Abbass, Pozzi, Chiara, et al. · Zenodo (CERN European Organization for Nuclear Research)
Dataset related to article "A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in COVID-19"
2021 · Pozzi*, Chiara, Levi*, Riccardo, et al. · Zenodo (CERN European Organization for Nuclear Research)
The Role of Chi3l1 in Breast Cancer¿a Driver of Immunosuppression on the Roadof Tumor Progression¿
2020 · DARWICH, ABBASS · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
L4 Synthetic agonistic receptor-activating BiTEs – a modular platform for the efficient targeting of acute myeloid leukemia
2020 · M Benmebarek, BL Cadilha, et al. · Journal for ImmunoTherapy of Cancer
PDF
Complement C3aR loss drives colorectal cancer by modulating gut microbiota
2020 · Silvia Guglietta, Sara Carloni, et al. · The Journal of Immunology
Works count: 16
Citation count: 258
H-index: 8
I10-index: 8
Year
Topic
Type